Why the study?
Does propranolol prevent or reverse experimentally induced cardiac arrhythmias in animal models?
Does propranolol prevent or reverse experimentally induced cardiac arrhythmias in animal models?
Answers are grounded in this paper and cite their sources.
Propranolol demonstrates potent antiarrhythmic activity in preclinical models, preventing sympathomimetic-induced arrhythmias and reversing ouabain-induced ventricular tachycardia.
Propranolol (Inderal), a new, potent, non-carcinogenic beta adrenergic receptor antagonist has been shown to possess antiarrhythmic activity when tested against experimentally induced cardiac arrhythmias. The potent beta adrenergic receptor inhibition produced by propranolol leads to a prevention of those cardiac arrhythmias resulting from a combination of a sensitizing agent and a sympathomimetic amine. Methylchloroform–adrenaline and U-0882–isoproterenol arrhythmias were prevented by previous administration of propranolol at a dose sufficient to produce beta adrenergic receptor blockade.Propranolol has been shown to be capable of reversing ventricular tachycardia associated with ouabain intoxication in the anesthetized dog. The agent exerts an effect upon the ouabain-induced ventricular automatic focus and abolishes the activity of the abnormal pacemaker. The mechanism, although unknown, is not believed to be associated with the ability of propranolol to produce beta adrenergic receptor blockade.
No takes yet. Share an insight, caveat, or question.
Lucchesi et al. (1966) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: